Clarius Group, LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$586,777
-53.8%
399,1680.0%0.06%
-42.9%
Q2 2023$1,269,354
+3178.9%
399,168
+2333.4%
0.10%
+3166.7%
Q1 2023$38,713
+67817.5%
16,4040.0%0.00%
-40.0%
Q4 2022$57
-100.0%
16,4040.0%0.01%
-58.3%
Q3 2022$120,000
+12.1%
16,4040.0%0.01%
+9.1%
Q2 2022$107,000
-15.7%
16,4040.0%0.01%
+10.0%
Q1 2022$127,0000.0%16,4040.0%0.01%0.0%
Q4 2021$127,00016,4040.01%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$156,056,00045.49%
Foresite Capital Management IV, LLC 13,282,181$102,804,00021.15%
Apoletto Ltd 15,093,969$116,827,00014.55%
SB Management Ltd 3,500,000$27,090,0002.68%
HSG Holding Ltd 3,045,997$23,576,0002.11%
MIC Capital Management UK LLP 1,320,000$10,217,0001.95%
Alphabet Inc. 5,865,125$45,396,0001.10%
Board of Trustees of The Leland Stanford Junior University 1,647,882$12,754,0000.80%
Adero Partners, LLC 491,372$3,803,0000.62%
Ergoteles LLC 1,008,428$7,805,0000.30%
View complete list of LYELL IMMUNOPHARMA INC shareholders